Ten years ago, Victoria Hale wrote a manifesto targeting five diseases in need of drug development and turned it into a business plan for the first pharmaceutical not-for-profit in the United States. Today, her organization, the Institute for OneWorld Health, is on the verge of proving that its no-profit/no-loss model can work. Its first drug, paromomycin — a treatment for visceral leishmaniasis, an illness spread by sand flies that mostly afflicts the poorest of the poor — is months from completing its final stage of clinical trials. Up next: malaria. Backed by a $42.6 million grant from the Gates Foundation, OneWorld Health aims to create and market semisynthetic artemisinin, a key malaria-fighting ingredient that’s in short supply.
The Most Innovative Companies
The top 50 companies in entertainment, media, sports, technology, and more.
Most Creative People
Meet this year's inspiring leaders.
Innovation By Design
A showcase for ingenious design solutions.
World Changing Ideas
New workplaces, new food sources, new medicine—even an entirely new economic system.
The apps, tips, tactics, and brain hacks to help you work smarter instead of harder.
An award-winning team of journalists, designers, and videographers who tell brand stories through Fast Company’s distinctive lens.